Marco Loggia

[1] He is known for his work on brain mechanisms of pain, especially using functional magnetic resonance imaging (fMRI)[2][3] and positron emission tomography (PET).

[4][5] He has been a pioneer in the use of Arterial Spin Labeling[6][7] and second-generation TSPO PET ligands for the study of chronic pain.

His work has been highlighted by many media outlets, including Popular Science,[8] New Scientist,[9] Scientific American,[10] ABC News,[11] la Repubblica,[12] Sky TG24,[13] the Harvard Gazette[14] and others.

In 2008 he was awarded a Ph.D. in Neurological Sciences by McGill University in Montreal, QC (Canada), under the mentorship of Prof. M. Catherine Bushnell.

"[14] His study of neuroinflammation in fibromyalgia,[5] conducted in collaboration with Karolinska Institutet, was named one of the "Top Ten Cell Science News Stories of 2018" by Technology Networks.